Ultralife Co. (NASDAQ:ULBI) Short Interest Update

Ultralife Co. (NASDAQ:ULBIGet Free Report) was the recipient of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 55,300 shares, a decline of 25.9% from the May 15th total of 74,600 shares. Currently, 0.6% of the company’s stock are sold short. Based on an average trading volume of 94,000 shares, the days-to-cover ratio is presently 0.6 days.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Benchmark lifted their target price on shares of Ultralife from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, March 5th. StockNews.com downgraded Ultralife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, May 2nd.

Check Out Our Latest Report on Ultralife

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Empowered Funds LLC grew its stake in shares of Ultralife by 7.8% during the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after buying an additional 2,275 shares during the last quarter. Perritt Capital Management Inc. boosted its stake in shares of Ultralife by 25.0% during the 1st quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after purchasing an additional 3,000 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Ultralife in the third quarter worth about $36,000. Pitti Group Wealth Management LLC lifted its holdings in Ultralife by 41.3% in the fourth quarter. Pitti Group Wealth Management LLC now owns 18,120 shares of the technology company’s stock worth $124,000 after buying an additional 5,300 shares during the period. Finally, Vanguard Group Inc. boosted its position in Ultralife by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock valued at $4,545,000 after acquiring an additional 6,640 shares in the last quarter. 30.68% of the stock is owned by hedge funds and other institutional investors.

Ultralife Stock Performance

NASDAQ ULBI traded down $0.40 on Friday, hitting $10.08. 29,381 shares of the stock traded hands, compared to its average volume of 77,060. Ultralife has a 12 month low of $4.60 and a 12 month high of $13.39. The business’s fifty day moving average is $10.86 and its two-hundred day moving average is $8.94. The firm has a market capitalization of $167.53 million, a price-to-earnings ratio of 15.92 and a beta of 0.99. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.16 and a current ratio of 4.03.

Ultralife (NASDAQ:ULBIGet Free Report) last issued its quarterly earnings results on Thursday, April 25th. The technology company reported $0.21 earnings per share (EPS) for the quarter. Ultralife had a return on equity of 10.31% and a net margin of 6.19%. The firm had revenue of $41.93 million during the quarter.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Recommended Stories

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.